Serum from HCV-HCC patients showed higher levels of MMP-2 and pentraxin-3 as well, but, in addition, exhibited increased levels of IL-6 and HGF in HCC compared to HCV-cirrhosis patients (Figure 3B,D). The gene discussed is IL6; the disease is hepatocellular carcinoma.